The status of HER2 in colorectal carcinoma and the relation of HER2 with prognostic parameters and MSI
Background: Colorectal cancer (CRC) is the third most commonly occurring cancer in men and the second most common cancer in women. Despite advances in surgical techniques and chemotherapeutic regimens, CRC continues to be one of the main causes of cancer-related deaths in the world. Aims: The aim of...
Saved in:
Main Authors: | Ismail Saygin (Author), Emel Cakir (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status
by: Sanaa Gamrani, et al.
Published: (2023) -
Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients
by: Gokce Deniz Ardor, et al.
Published: (2023) -
Temporal and spatial heterogeneity of HER2 status in metastatic colorectal cancer
by: Flavia D'Angelo, et al.
Published: (2024) -
HER2 (ERBB2) alterations in colorectal cancers
by: Nika Tavberidze, et al.
Published: (2022) -
Concordance between immunohistochemistry and MSI analysis for detection of MMR/MSI status in colorectal cancer patients
by: Muhammad Ishaque Faizee, et al.
Published: (2024)